Novo: Oral model of Ozempic results in 15% weight reduction
An oral model of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight reduction in a trial...
Oral
Level-Of-Care Biosensor to Detect Oral Most cancers
Researchers on the College of Florida have created a point-of-care biosensor that may quickly detect a biomarker for oral most...
